The Wall Street Journal reported that executives across Elon Musk's companies are worried about his drug use, as Katherine Tangalakis-Lippert and Hannah Getahun reported for Business Insider.
Tesla board members were reportedly concerned Musk was on drugs when he made his "funding secured" tweet.
The outlet reported that Tesla board members were concerned Musk was on drugs when he made his "funding secured" tweet.
A former director at Tesla was so concerned about Elon Musk's drug use and unpredictable behavior that she chose not to stand for reelection to the electric car company's board, according to a new report from The Wall Street Journal.
Linda Johnson Rice, who served a two-year term on the company's board ending in 2019, confided in Tesla board members on more than one occasion about her worries related to his substance use, The Journal reported.
Rice also informally asked if the board should investigate Musk's drug use — which includes ketamine, LSD, cocaine, and ecstasy, according to people familiar with the matter — but her concerns were ignored, per the outlet.
The extensive report from The Journal details how executives across Musk's companies have grappled with how to manage his drug use and erratic public appearances and statements.
At Tesla, some current directors have sought out help from Musk's brother, Kimbal, over his behavior, but The Journal reported they have been careful not to use the word "drugs" when relaying their concerns.
Comments